US Patent 10064875 | Patents | Expiry | Expiration | Dates

ENCORE DERMAT

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Post An Enquiry

Virtual Booth

CLOBETASOL PROPIONATE

Supporting Information : Click here to upload a PDF

US Patent Number

10064875

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2030-08-31

Patent Use Code

U-742

Delist Requested

Application Number

209483

Patent Use Description

TWICE DAILY TOPICAL TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS.

Product Number

1

ENCORE DERMAT

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Post An Enquiry

Virtual Booth

CLOBETASOL PROPIONATE

Supporting Information : Click here to upload a PDF

US Patent Number

10064875

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2030-08-31

Patent Use Code

U-1408

Delist Requested

Application Number

209483

Patent Use Description

TREATMENT OF PLAQUE PSORIASIS IN PATIENTS 18 YEARS OF AGE OR OLDER

Product Number

1

ENCORE DERMAT

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Post An Enquiry

Virtual Booth

CLOBETASOL PROPIONATE

Supporting Information : Click here to upload a PDF

US Patent Number

10064875

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2030-08-31

Patent Use Code

U-193

Delist Requested

Application Number

209483

Patent Use Description

PSORIASIS

Product Number

1

ENCORE DERMAT

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Post An Enquiry

Virtual Booth

CLOBETASOL PROPIONATE

Supporting Information : Click here to upload a PDF

US Patent Number

10064875

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2030-08-31

Patent Use Code

U-1858

Delist Requested

Application Number

209483

Patent Use Description

TREATMENT OF PLAQUE PSORIASIS

Product Number

1

ENCORE DERMAT

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Post An Enquiry

Virtual Booth

CLOBETASOL PROPIONATE

Supporting Information : Click here to upload a PDF

US Patent Number

10064875

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2030-08-31

Patent Use Code

U-88

Delist Requested

Application Number

209483

Patent Use Description

TREATMENT OF MODERATE PLAQUE PSORIASIS

Product Number

Find

Information, Expiry & Status of FDA Orange Book Patents covering 10064875

ENCORE DERMAT

Y

2030-08-31

U-742

TWICE DAILY TOPICAL TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS.

1

ENCORE DERMAT

Y

2030-08-31

U-1408

TREATMENT OF PLAQUE PSORIASIS IN PATIENTS 18 YEARS OF AGE OR OLDER

1

ENCORE DERMAT

Y

2030-08-31

U-193

PSORIASIS

1

ENCORE DERMAT

Y

2030-08-31

U-1858

TREATMENT OF PLAQUE PSORIASIS

1

ENCORE DERMAT

Y

2030-08-31

U-88

TREATMENT OF MODERATE PLAQUE PSORIASIS

1